Genomic structure and chromosomal mapping of the gene coding for ICBP90, a protein involved in the regulation of the topoisomerase IIα gene expression

Gene

Volumn 266, Issue 1-2, 2001, Pages 15-23

  Hopfner, Raphaël ^a,b   Mousli, Marc ^a,b,c   Garnier, Jean Marie ^a,b   Redon, Richard ^a,b   Du Manoir, Stanislas ^a,b   Chatton, Bruno ^a,b   Ghyselinck, Norbert ^a,b   Oudet, Pierre ^a,b   Bronner, Christian ^a,b,c  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b Communauté Urbaine De Strasbourg ^*  (France)

^c INSERM   (France)

Author keywords

Cancer; Cell proliferation; Gene expression; ICBP90

Indexed keywords

BINDING PROTEIN; DNA TOPOISOMERASE (ATP HYDROLYSING); PROTEIN ICBP90; UNCLASSIFIED DRUG;

ARTICLE; BURKITT LYMPHOMA; CANCER CELL; CELL LINE; CELL PROLIFERATION; CELL SPECIFICITY; CHROMOSOME MAP; CHRONIC MYELOID LEUKEMIA; COLORECTAL CARCINOMA; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE SEQUENCE; GENE STRUCTURE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUNG CARCINOMA; LUNG FIBROBLAST; PLACENTA; PRIORITY JOURNAL; PROMOTER REGION; PROMYELOCYTIC LEUKEMIA; RAJI CELL; SEQUENCE HOMOLOGY; T LYMPHOCYTE;

ALTERNATIVE SPLICING; ANIMALS; ANTIGENS, NEOPLASM; BASE SEQUENCE; BLOTTING, NORTHERN; CCAAT-ENHANCER-BINDING PROTEINS; CHLORAMPHENICOL O-ACETYLTRANSFERASE; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 19; COS CELLS; DNA; DNA TOPOISOMERASES, TYPE II; DNA TOPOISOMERASES, TYPE II, EUKARYOTIC; DNA-BINDING PROTEINS; EXONS; GENE EXPRESSION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENES; HL-60 CELLS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTRONS; ISOENZYMES; K562 CELLS; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); RECOMBINANT FUSION PROTEINS; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; TUMOR CELLS, CULTURED;

EID: 0035925620     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1119(01)00371-7     Document Type: Article

References (26)

1. Cell-cycle regulation of the DNA topoisomerase IIα promoter is mediated by proximal CCAAT boxes: Possible involvement of acetylation
2. Expression of a beta-globin gene is enhanced by remote SV40 DNA sequences
3. The human junD gene is postively and selectively autoregulated
4. Organization and expression of eucaryotic split genes coding for proteins
5. Genetic approaches to the study of the molecular basis of human cancer
6. Evidence for repressional role of an inverted CCAAT box in cell cycle-dependent transcription of the human DNA topoisomerase IIα gene
7. Structure and expression of the ATFa gene
8. Pathogenesis of adenocarcinoma in Peutz-Jeghers syndrome
9. Identification of de novo chromosomal markers and derivatives by spectral karyotyping
10. Evaluation of a potential regulatory role for inverted CCAAT boxes in the human topoisomerase IIα promoter
11. Cloning and characterization of the 5′-flanking region of the human topoisomerase II alpha gene
12. Cytogenetic and fluorescence in situ hybridization analyses of chromosome 19 aberrations in pancreatic carcinomas: Frequent loss of 19p13.3 and gain of 19q13.1-13.2
13. ICBP90, a novel CCAAT binding protein, involved in the regulation of topoisomerase IIα expression
14. Regulation of the human topoisomerase IIalpha gene promoter in confluence-arrested cells
15. DNA topoisomerase II alpha gene expression under transcriptional control in etoposide/teniposide-resistant human cancer cells
16. A distinct region of chromosome 19p13.3 associated with the sporadic form of adenoma malignum of the uterine cervix
17. Promoter region of the human CRE-BP1 gene encoding the transcriptional regulator binding to the cyclic AMP response element
18. Genomic organization of the human oestrogen receptor gene
19. Chromosomal localization of the four genes (NFIA, B, C, and X) for the human transcription factor nuclear factor I by FISH
20. Large scale sequencing specific neural networks for promoter and splice site recognition
21. p53 regulates the minimal promoter of the human topoisomerase IIalpha gene
22. Atypical (7;19) translocation in acute myelomonocytic leukemia
23. Non-random chromosomal rearrangements and their implications in features and outcome of multiple myeloma and plasma cell leukemia
24. Inhibition of topoisomerase II alpha gene expression by the p53 tumor suppressor